2-Nitroimidazole CAS 527-73-1 Purity >98.0% (HPLC) Factory Main Product

Short Description:

Chemical Name: 2-Nitroimidazole 

CAS: 527-73-1

Purity: >98.0% (HPLC)

Appearance: Light Yellow Crystal Powder

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Manufacturer Supply, High Purity, Commercial Production 
Chemical Name: 2-Nitroimidazole CAS: 527-73-1

Chemical Properties:

Chemical Name 2-Nitroimidazole
Synonyms Azomycin; 2-Nitro-1H-Imidazole
CAS Number 527-73-1
CAT Number RF-PI967
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C3H3N3O2
Molecular Weight 113.08
Melting Point 287℃ (dec.) (lit.)
Solubility Soluble in Methanol, Ethanol, Acetone; Insoluble in Chloroform, Ether
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Light Yellow Crystal Powder 
Purity / Analysis Method  >98.0% (HPLC)
Loss on Drying ≤1.0%
Total Impurities <2.0%
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

1

FAQ:

Application:

2-Nitroimidazole (CAS: 527-73-1) is used as an intermediate in organic synthesis. It is the basic raw material for the synthesis and manufacture of nitroimidazole compounds in electrophilic radiosensitizers. N-substituted derivatives prepared from 2-Nitroimidazole have been used as antitumor radiosensitizers in clinical studies. 2-Nitroimidazole is an important intermediate in a variety of tumor radiotherapy sensitizers, such as Misonidazole, Pimonidazole, Etanidazole, etc. 2-Nitroimidazole is a antibiotic substance produced by an unidentified Streptomyces,it is used to prepare nitroimidazole substituted boronic acids as precursors for imaging hypoxic tissue 1. It is also used to prepare potential site-selective radiosensitizers for estrogen receptor-rich tumors.

  • Write your message here and send it to us